Folgen
Phuc Felix Nguyen-tan
Phuc Felix Nguyen-tan
CHUM
Bestätigte E-Mail-Adresse bei ssss.gouv.qc.ca
Titel
Zitiert von
Zitiert von
Jahr
Human papillomavirus and survival of patients with oropharyngeal cancer
KK Ang, J Harris, R Wheeler, R Weber, DI Rosenthal, PF Nguyen-Tân, ...
New England Journal of Medicine 363 (1), 24-35, 2010
68472010
Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522
KK Ang, Q Zhang, DI Rosenthal, PF Nguyen-Tan, EJ Sherman, RS Weber, ...
Journal of clinical oncology 32 (27), 2940, 2014
8302014
Radiomics strategies for risk assessment of tumour failure in head-and-neck cancer
M Vallières, E Kay-Rivest, LJ Perrin, X Liem, C Furstoss, HJWL Aerts, ...
Scientific reports 7 (1), 10117, 2017
5302017
Human papillomavirus and overall survival after progression of oropharyngeal squamous cell carcinoma
C Fakhry, Q Zhang, PF Nguyen-Tan, D Rosenthal, A El-Naggar, ...
Journal of clinical oncology 32 (30), 3365, 2014
5242014
Randomized phase III trial to test accelerated versus standard fractionation in combination with concurrent cisplatin for head and neck carcinomas in the Radiation Therapy …
PF Nguyen-Tan, Q Zhang, KK Ang, RS Weber, DI Rosenthal, D Soulieres, ...
Journal of Clinical Oncology 32 (34), 3858, 2014
4772014
Institutional clinical trial accrual volume and survival of patients with head and neck cancer
EJ Wuthrick, Q Zhang, M Machtay, DI Rosenthal, PF Nguyen-Tan, A Fortin, ...
Journal of Clinical Oncology 33 (2), 156, 2015
2462015
A randomized phase III trial (RTOG 0522) of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III-IV head and neck squamous cell carcinomas (HNC).
KK Ang, QE Zhang, DI Rosenthal, P Nguyen-Tan, EJ Sherman, RS Weber, ...
Journal of Clinical Oncology 29 (15_suppl), 5500-5500, 2011
2212011
Treatment results and prognostic factors of advanced T3–4 laryngeal carcinoma: the University of California, San Francisco (UCSF) and Stanford University Hospital (SUH) experience
PF Nguyen-Tan, QT Le, JM Quivey, M Singer, DJ Terris, DR Goffinet, ...
International Journal of Radiation Oncology* Biology* Physics 50 (5), 1172-1180, 2001
1572001
Development and validation of nomograms predictive of overall and progression-free survival in patients with oropharyngeal cancer
C Fakhry, Q Zhang, PF Nguyen-Tân, DI Rosenthal, RS Weber, L Lambert, ...
Journal of Clinical Oncology 35 (36), 4057, 2017
1372017
Symptom clusters in patients with head and neck cancer receiving concurrent chemoradiotherapy
C Xiao, A Hanlon, Q Zhang, K Ang, DI Rosenthal, PF Nguyen-Tan, H Kim, ...
Oral oncology 49 (4), 360-366, 2013
1152013
Survival outcomes by tumor human papillomavirus (HPV) status in stage III-IV oropharyngeal cancer (OPC) in RTOG 0129
ML Gillison, J Harris, W Westra, C Chung, R Jordan, D Rosenthal, ...
Journal of Clinical Oncology 27 (15_suppl), 6003-6003, 2009
1132009
A phase II trial of dacomitinib, an oral pan-human EGF receptor (HER) inhibitor, as first-line treatment in recurrent and/or metastatic squamous-cell carcinoma of the head and neck
ARA Razak, D Soulieres, SA Laurie, SJ Hotte, S Singh, E Winquist, ...
Annals of oncology 24 (3), 761-769, 2013
1122013
Aetiological heterogeneity of head and neck squamous cell carcinomas: the role of human papillomavirus infections, smoking and alcohol
NJ Farsi, MC Rousseau, N Schlecht, G Castonguay, P Allison, ...
Carcinogenesis 38 (12), 1188-1195, 2017
912017
Organ preservation with concurrent chemoradiation for advanced laryngeal cancer: are we succeeding?
L Lambert, B Fortin, D Soulières, L Guertin, G Coulombe, D Charpentier, ...
International Journal of Radiation Oncology* Biology* Physics 76 (2), 398-402, 2010
862010
18F-FDG-PET imaging in radiotherapy tumor volume delineation in treatment of head and neck cancer
G Delouya, L Igidbashian, A Houle, M Bélair, L Boucher, C Cohade, ...
Radiotherapy and Oncology 101 (3), 362-368, 2011
852011
Impact of weight loss on survival after chemoradiation for locally advanced head and neck cancer: secondary results of a randomized phase III trial (SAKK 10/94)
P Ghadjar, S Hayoz, F Zimmermann, S Bodis, D Kaul, H Badakhshi, ...
Radiation oncology 10, 1-7, 2015
752015
Enteral feeding during chemoradiotherapy for advanced head-and-neck cancer: a single-institution experience using a reactive approach
S Clavel, B Fortin, P Després, D Donath, D Soulières, N Khaouam, ...
International Journal of Radiation Oncology* Biology* Physics 79 (3), 763-769, 2011
702011
Simultaneous integrated boost using intensity-modulated radiotherapy compared with conventional radiotherapy in patients treated with concurrent carboplatin and 5-fluorouracil …
S Clavel, DHA Nguyen, B Fortin, P Després, N Khaouam, D Donath, ...
International Journal of Radiation Oncology* Biology* Physics 82 (2), 582-589, 2012
692012
The KRAS-variant and cetuximab response in head and neck squamous cell cancer: a secondary analysis of a randomized clinical trial
JB Weidhaas, J Harris, D Schaue, AM Chen, R Chin, R Axelrod, ...
JAMA oncology 3 (4), 483-491, 2017
642017
Validation of NRG oncology/RTOG‐0129 risk groups for HPV‐positive and HPV‐negative oropharyngeal squamous cell cancer: implications for risk‐based therapeutic intensity trials
C Fakhry, Q Zhang, ML Gillison, PF Nguyen‐Tân, DI Rosenthal, ...
Cancer 125 (12), 2027-2038, 2019
612019
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20